HEADER IMMUNE SYSTEM 11-JAN-12 4AEN TITLE HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 26-217; COMPND 5 SYNONYM: MHC CLASS II ANTIGEN DRA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DRB1-1 BETA CHAIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 30-227; COMPND 11 SYNONYM: MHC CLASS II ANTIGEN DRB1*1, DR-1, DR1; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN GAMMA CHAIN; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: RESIDUES 106-120; COMPND 17 SYNONYM: HLA-DR ANTIGENS-ASSOCIATED INVARIANT CHAIN, IA ANTIGEN- COMPND 18 ASSOCIATED INVARIANT CHAIN, II, P33, CD74; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET11A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PET24D; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_VECTOR: PET11A KEYWDS IMMUNE SYSTEM, SELF ANTIGEN, INVARIANT CHAIN, CLIP EXPDTA X-RAY DIFFRACTION AUTHOR A.SCHLUNDT,S.GUENTHER,J.STICHT,M.WIECZOREK,Y.ROSKE,U.HEINEMANN, AUTHOR 2 C.FREUND REVDAT 3 20-DEC-23 4AEN 1 REMARK REVDAT 2 10-OCT-12 4AEN 1 JRNL REVDAT 1 01-AUG-12 4AEN 0 JRNL AUTH A.SCHLUNDT,S.GUNTHER,J.STICHT,M.WIECZOREK,Y.ROSKE, JRNL AUTH 2 U.HEINEMANN,C.FREUND JRNL TITL PEPTIDE LINKAGE TO THE ALPHA-SUBUNIT OF MHCII CREATES A JRNL TITL 2 STABLY INVERTED ANTIGEN PRESENTATION COMPLEX. JRNL REF J.MOL.BIOL. V. 423 294 2012 JRNL REFN ISSN 0022-2836 JRNL PMID 22820093 JRNL DOI 10.1016/J.JMB.2012.07.008 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 27006 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1351 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.4185 - 4.7361 1.00 2701 143 0.1893 0.2028 REMARK 3 2 4.7361 - 3.7607 1.00 2609 137 0.1516 0.1996 REMARK 3 3 3.7607 - 3.2857 1.00 2558 135 0.1670 0.1895 REMARK 3 4 3.2857 - 2.9855 1.00 2581 135 0.1827 0.2346 REMARK 3 5 2.9855 - 2.7716 1.00 2531 134 0.1882 0.2061 REMARK 3 6 2.7716 - 2.6082 1.00 2550 134 0.1949 0.2428 REMARK 3 7 2.6082 - 2.4777 1.00 2537 133 0.2034 0.2477 REMARK 3 8 2.4777 - 2.3698 1.00 2548 135 0.2171 0.2577 REMARK 3 9 2.3698 - 2.2786 1.00 2491 131 0.2250 0.3048 REMARK 3 10 2.2786 - 2.2000 1.00 2549 134 0.2212 0.2944 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.86 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 32.50 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.560 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.85220 REMARK 3 B22 (A**2) : 5.20400 REMARK 3 B33 (A**2) : 5.42650 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3143 REMARK 3 ANGLE : 1.053 4267 REMARK 3 CHIRALITY : 0.070 461 REMARK 3 PLANARITY : 0.005 554 REMARK 3 DIHEDRAL : 14.157 1147 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: OWING TO DISORDER FOLLOWING RESIDUES REMARK 3 ARE MISSING COMPLETELY A-14-A2, A181-A192, B0-B2, B106-B112, REMARK 3 B191-B198, C105. OWING TO DISORDER FOLLOWING RESIDUES COULD ONLY REMARK 3 BE MODELED TO THE CBETA-ATOM A3, B105, B166, C120 REMARK 4 REMARK 4 4AEN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1290050876. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : SI-111 CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27008 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 34.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3PDO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 M (NH4)2SO4, 0.1 M TRIS, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.09800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.55550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.09800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 72.55550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.09800 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 72.55550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.09800 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 72.55550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2050 LIES ON A SPECIAL POSITION. REMARK 375 HOH C2002 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -14 REMARK 465 GLY A -13 REMARK 465 GLY A -12 REMARK 465 GLY A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 GLY A -8 REMARK 465 GLY A -7 REMARK 465 GLY A -6 REMARK 465 SER A -5 REMARK 465 GLY A -4 REMARK 465 GLY A -3 REMARK 465 GLY A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 ILE A 1 REMARK 465 LYS A 2 REMARK 465 ASP A 181 REMARK 465 ALA A 182 REMARK 465 PRO A 183 REMARK 465 SER A 184 REMARK 465 PRO A 185 REMARK 465 LEU A 186 REMARK 465 PRO A 187 REMARK 465 GLU A 188 REMARK 465 THR A 189 REMARK 465 THR A 190 REMARK 465 GLU A 191 REMARK 465 ASN A 192 REMARK 465 MET B 0 REMARK 465 GLY B 1 REMARK 465 ASP B 2 REMARK 465 THR B 106 REMARK 465 GLN B 107 REMARK 465 PRO B 108 REMARK 465 LEU B 109 REMARK 465 GLN B 110 REMARK 465 HIS B 111 REMARK 465 HIS B 112 REMARK 465 ARG B 191 REMARK 465 SER B 192 REMARK 465 GLU B 193 REMARK 465 SER B 194 REMARK 465 ALA B 195 REMARK 465 GLN B 196 REMARK 465 SER B 197 REMARK 465 LYS B 198 REMARK 465 MET C 105 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 3 CG CD OE1 OE2 REMARK 470 LYS B 105 CG CD CE NZ REMARK 470 ARG B 166 CG CD NE CZ NH1 NH2 REMARK 470 MET C 120 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 100 -9.10 72.48 REMARK 500 SER A 156 117.94 -167.35 REMARK 500 ASN B 33 -101.09 55.97 REMARK 500 TYR B 78 -69.07 -120.29 REMARK 500 THR B 90 -74.98 -123.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1191 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1181 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB REMARK 900 RELATED ID: 1KG0 RELATED DB: PDB REMARK 900 STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TOTHE MHC REMARK 900 CLASS II RECEPTOR HLA-DR1 REMARK 900 RELATED ID: 1IIE RELATED DB: PDB REMARK 900 MHC CLASS II-ASSOCIATED INVARIANT CHAIN (II) HUMAN ECTOPLASMIC REMARK 900 TRIMERIZATION DOMAIN REMARK 900 RELATED ID: 1D5M RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE REMARK 900 RELATED ID: 1ICF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN REMARK 900 COMPLEX WITH CATHEPSIN L REMARK 900 RELATED ID: 1HXY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H INCOMPLEX WITH REMARK 900 HUMAN MHC CLASS II REMARK 900 RELATED ID: 1LO5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCALENTEROTOXIN REMARK 900 A IN COMPLEX WITH HUMAN MHC CLASS II REMARK 900 RELATED ID: 1SEB RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA- DR1 ANDTHE REMARK 900 BACTERIAL SUPERANTIGEN SEB REMARK 900 RELATED ID: 1JWS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS IIMOLECULE HLA- REMARK 900 DR1 (HA PEPTIDE 306-318) WITH THESUPERANTIGEN SEC3 VARIANT 3B1 REMARK 900 RELATED ID: 1H15 RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A REMARK 900 PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE. REMARK 900 RELATED ID: 2SEB RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM REMARK 900 HUMAN COLLAGEN II REMARK 900 RELATED ID: 1SJH RELATED DB: PDB REMARK 900 HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE REMARK 900 RELATED ID: 1FV1 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANTPEPTIDE FROM REMARK 900 MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BYTWO HLA-DR2 ALLELES REMARK 900 RELATED ID: 1JWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS IIMOLECULE HLA- REMARK 900 DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGENSEC3 REMARK 900 RELATED ID: 2XN9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL REMARK 900 RECEPTOR, STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEX CLASS II REMARK 900 RELATED ID: 1KLU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED REMARK 900 WITHSTAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2) REMARK 900 RELATED ID: 1FYT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA -T REMARK 900 CELLRECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS REMARK 900 IIMOLECULE, HLA-DR1 REMARK 900 RELATED ID: 1YMM RELATED DB: PDB REMARK 900 TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX REMARK 900 RELATED ID: 1ZGL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A REMARK 900 RELATED ID: 1J8H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA -T REMARK 900 CELLRECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS REMARK 900 IIMOLECULE, HLA-DR4 REMARK 900 RELATED ID: 1L3H RELATED DB: PDB REMARK 900 NMR STRUCTURE OF P41ICF, A POTENT INHIBITOR OF HUMANCATHEPSIN L REMARK 900 RELATED ID: 1MUJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEXWITH A REMARK 900 HUMAN CLIP PEPTIDE REMARK 900 RELATED ID: 1T5W RELATED DB: PDB REMARK 900 HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE( AAYSDQATPLLLSPR) REMARK 900 RELATED ID: 1D5X RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC REMARK 900 RELATED ID: 1KLG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) REMARK 900 COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2(SEC3-3B2) REMARK 900 RELATED ID: 2G9H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) INCOMPLEX REMARK 900 WITH A HUMAN MHC CLASS II MOLECULE REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1DLH RELATED DB: PDB REMARK 900 RELATED ID: 1SJE RELATED DB: PDB REMARK 900 HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDEBOUND IN A REMARK 900 HAIRPIN CONFORMATION REMARK 900 RELATED ID: 1D5Z RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC REMARK 900 RELATED ID: 1JWU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS IIMOLECULE HLA- REMARK 900 DR1 (HA PEPTIDE 306-318) WITH THESUPERANTIGEN SEC3 VARIANT 3B2 REMARK 900 RELATED ID: 1T5X RELATED DB: PDB REMARK 900 HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE( AAYSDQATPLLLSPR) AND REMARK 900 THE SUPERANTIGEN SEC3-3B2 REMARK 900 RELATED ID: 1A6A RELATED DB: PDB REMARK 900 THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP REMARK 900 BOUND TO HLA-DR3 REMARK 900 RELATED ID: 4AH2 RELATED DB: PDB REMARK 900 HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN CANONICAL ORIENTATION DBREF 4AEN A 1 192 UNP P01903 DRA_HUMAN 26 217 DBREF 4AEN B 1 198 UNP P04229 2B11_HUMAN 30 227 DBREF 4AEN C 106 120 UNP P04233 HG2A_HUMAN 106 120 SEQADV 4AEN GLY A -14 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -13 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -12 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -11 UNP P01903 EXPRESSION TAG SEQADV 4AEN SER A -10 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -9 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -8 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -7 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -6 UNP P01903 EXPRESSION TAG SEQADV 4AEN SER A -5 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -4 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -3 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -2 UNP P01903 EXPRESSION TAG SEQADV 4AEN GLY A -1 UNP P01903 EXPRESSION TAG SEQADV 4AEN SER A 0 UNP P01903 EXPRESSION TAG SEQADV 4AEN MET B 0 UNP P04229 EXPRESSION TAG SEQADV 4AEN MET C 105 UNP P04233 EXPRESSION TAG SEQRES 1 A 207 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLY GLY GLY SEQRES 2 A 207 GLY SER ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU SEQRES 3 A 207 PHE TYR LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE SEQRES 4 A 207 ASP PHE ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA SEQRES 5 A 207 LYS LYS GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG SEQRES 6 A 207 PHE ALA SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE SEQRES 7 A 207 ALA VAL ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SEQRES 8 A 207 SER ASN TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL SEQRES 9 A 207 THR VAL LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO SEQRES 10 A 207 ASN VAL LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO SEQRES 11 A 207 VAL VAL ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL SEQRES 12 A 207 THR THR GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU SEQRES 13 A 207 ASP HIS LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU SEQRES 14 A 207 PRO SER THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS SEQRES 15 A 207 TRP GLY LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE SEQRES 16 A 207 ASP ALA PRO SER PRO LEU PRO GLU THR THR GLU ASN SEQRES 1 B 199 MET GLY ASP THR ARG PRO ARG PHE LEU TRP GLN LEU LYS SEQRES 2 B 199 PHE GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG SEQRES 3 B 199 LEU LEU GLU ARG CYS ILE TYR ASN GLN GLU GLU SER VAL SEQRES 4 B 199 ARG PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR SEQRES 5 B 199 GLU LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN SEQRES 6 B 199 LYS ASP LEU LEU GLU GLN ARG ARG ALA ALA VAL ASP THR SEQRES 7 B 199 TYR CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR SEQRES 8 B 199 VAL GLN ARG ARG VAL GLU PRO LYS VAL THR VAL TYR PRO SEQRES 9 B 199 SER LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL SEQRES 10 B 199 CYS SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL SEQRES 11 B 199 ARG TRP PHE ARG ASN GLY GLN GLU GLU LYS ALA GLY VAL SEQRES 12 B 199 VAL SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE SEQRES 13 B 199 GLN THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY SEQRES 14 B 199 GLU VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SEQRES 15 B 199 SER PRO LEU THR VAL GLU TRP ARG ALA ARG SER GLU SER SEQRES 16 B 199 ALA GLN SER LYS SEQRES 1 C 16 MET LYS MET ARG MET ALA THR PRO LEU LEU MET GLN ALA SEQRES 2 C 16 LEU PRO MET HET GOL A1181 6 HET GOL B1191 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 HOH *249(H2 O) HELIX 1 1 LEU A 45 ARG A 50 5 6 HELIX 2 2 GLU A 55 SER A 77 1 23 HELIX 3 3 THR B 51 LEU B 53 5 3 HELIX 4 4 GLY B 54 SER B 63 1 10 HELIX 5 5 GLN B 64 GLU B 87 1 24 HELIX 6 6 SER B 88 THR B 90 5 3 SHEET 1 AA 8 GLU A 40 TRP A 43 0 SHEET 2 AA 8 ASP A 29 ASP A 35 -1 O HIS A 33 N VAL A 42 SHEET 3 AA 8 SER A 19 PHE A 26 -1 O PHE A 22 N VAL A 34 SHEET 4 AA 8 GLU A 4 ASN A 15 -1 O ILE A 8 N ASP A 25 SHEET 5 AA 8 PHE B 7 PHE B 18 -1 O PHE B 7 N ASN A 15 SHEET 6 AA 8 ARG B 23 TYR B 32 -1 O ARG B 23 N PHE B 18 SHEET 7 AA 8 GLU B 35 ASP B 41 -1 O GLU B 35 N TYR B 32 SHEET 8 AA 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AB 2 ALA A 52 SER A 53 0 SHEET 2 AB 2 GLN C 116 ALA C 117 -1 O GLN C 116 N SER A 53 SHEET 1 AC 4 GLU A 88 THR A 93 0 SHEET 2 AC 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AC 4 PHE A 145 PHE A 153 -1 O PHE A 145 N PHE A 112 SHEET 4 AC 4 LEU A 138 PRO A 139 1 O LEU A 138 N ARG A 146 SHEET 1 AD 4 GLU A 88 THR A 93 0 SHEET 2 AD 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AD 4 PHE A 145 PHE A 153 -1 O PHE A 145 N PHE A 112 SHEET 4 AD 4 SER A 133 GLU A 134 -1 O SER A 133 N TYR A 150 SHEET 1 AE 2 LEU A 138 PRO A 139 0 SHEET 2 AE 2 PHE A 145 PHE A 153 1 O ARG A 146 N LEU A 138 SHEET 1 AF 4 LYS A 126 PRO A 127 0 SHEET 2 AF 4 ASN A 118 ARG A 123 -1 O ARG A 123 N LYS A 126 SHEET 3 AF 4 TYR A 161 GLU A 166 -1 O ASP A 162 N LEU A 122 SHEET 4 AF 4 LEU A 174 TRP A 178 -1 O LEU A 174 N VAL A 165 SHEET 1 BA 4 LYS B 98 PRO B 103 0 SHEET 2 BA 4 LEU B 114 PHE B 122 -1 O VAL B 116 N TYR B 102 SHEET 3 BA 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 BA 4 ILE B 148 GLN B 149 1 O ILE B 148 N GLN B 156 SHEET 1 BB 4 LYS B 98 PRO B 103 0 SHEET 2 BB 4 LEU B 114 PHE B 122 -1 O VAL B 116 N TYR B 102 SHEET 3 BB 4 PHE B 155 GLU B 162 -1 O PHE B 155 N PHE B 122 SHEET 4 BB 4 VAL B 142 SER B 144 -1 O VAL B 143 N MET B 160 SHEET 1 BC 2 ILE B 148 GLN B 149 0 SHEET 2 BC 2 PHE B 155 GLU B 162 1 O GLN B 156 N ILE B 148 SHEET 1 BD 4 GLN B 136 GLU B 138 0 SHEET 2 BD 4 GLU B 128 ARG B 133 -1 O TRP B 131 N GLU B 138 SHEET 3 BD 4 TYR B 171 GLU B 176 -1 O THR B 172 N PHE B 132 SHEET 4 BD 4 LEU B 184 TRP B 188 -1 O LEU B 184 N VAL B 175 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.02 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.07 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.03 CISPEP 1 ASN A 15 PRO A 16 0 3.98 CISPEP 2 THR A 113 PRO A 114 0 -0.78 CISPEP 3 TYR B 123 PRO B 124 0 3.04 SITE 1 AC1 2 HIS B 81 HOH B2090 SITE 1 AC2 2 LYS A 111 ARG A 140 CRYST1 66.196 145.111 108.777 90.00 90.00 90.00 C 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015107 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006891 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009193 0.00000